Looking to publish in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowAmyotrophic Lateral Sclerosis and Frontotemporal Degeneration publishes research on motor neuron diseases, especially ALS and cognitive decline associated with frontotemporal degeneration. It is the official journal of the World Federation of Neurology Research Group on Motor Neuron Diseases and covers topics including cognitive decline, basic science, genetics, new treatments and clinical trials, epidemiology, and clinical neurophysiology.
Looking to publish in Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration accepts the following article types. Click on an article type to view submission instructions.
Original Articles
Reviews
Non-Systematic Reviews
Reports
Case Reports
Other Short Reports
Short Reports
Correspondence
Recent Publications
Brain activity in an end-stage ALS patient suggests the presence of an unresponsive wakefulness syndrome
Sandra Frycz, Wiktor Więcławski, Marcin Skotniczny, Marek Binder
Innate immune signaling as a potential pathomechanistic biomarker for distinct subtypes in amyotrophic lateral sclerosis
Marcel Naumann, Stefanie Kretschmer, Johannes Dorst, Hanna Lapp, Kevin Peikert, Susanne Petri, Burkhard Gess, Christine Wolf, Annekathrin Rödiger, Uta Smesny, Francisco Pan-Montojo, Philippe Kerschen, Torsten Grehl, Johannes Prudlo, Martin Regensburger, Albert Ludolph, René Günther, David Brenner, Min Ae Lee-Kirsch, Andreas Hermann
Whole-body muscle MRI improves diagnostic certainty in amyotrophic lateral sclerosis
Vincent Fabry, Marie Faruch-Bilfeld, Rokia El Khalfi, Blandine Acket, Yassine Al Achram, Pascal Cintas
Impact of treatment burden on medication adherence and quality of life in amyotrophic lateral sclerosis: a prospective multicentre study
Andrea Lizio, Matteo Farè, Francesca Gerardi, Marianna Collesi, Valeria Ada Sansone, Christian Lunetta, Luca Diamanti, Federica Cerri
Oligogenic variants in NEK1 and ATXN2 in amyotrophic lateral sclerosis: report of two cases and review of the literature
Émy Roy, Mathieu Blais, Patrick Dion, Guy A. Rouleau, Nicolas Dupré, Vincent Picher-Martel
Frequently asked questions
How long does it take to publish?
Average median timelines are tracked for submission to first decision, submission to first post-review decision, and acceptance to online publication, but no numerical values are stated.
Reformat to Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration using Livewrite PremiumIs a cover letter required?
Cover letters are discussed in a related resource.
Reformat to Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration using Livewrite PremiumWhat are the publication costs?
Institutional online-only subscription: USD 3,081.00; print and online subscription: USD 4,504.00.
Reformat to Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration using Livewrite Premium